Bryonamide B

CAS No. 5942-25-6

Bryonamide B( —— )

Catalog No. M37731 CAS No. 5942-25-6

Bryonamide B is a cucurbitane triterpene that can be extracted from Bryonia aspera.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 64 In Stock
2MG 36 In Stock
5MG 59 In Stock
10MG 86 In Stock
25MG 145 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Bryonamide B
  • Note
    Research use only, not for human use.
  • Brief Description
    Bryonamide B is a cucurbitane triterpene that can be extracted from Bryonia aspera.
  • Description
    Bryonamide B is a cucurbitane-type triterpenoid isolated from Bryonia aspera.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    5942-25-6
  • Formula Weight
    211.21
  • Molecular Formula
    C10H13NO4
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    C(NCCO)(=O)C1=CC(OC)=C(O)C=C1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Shamim Sahranavard, et al. New cucurbitane-type triterpenoids from Bryonia aspera. Planta Med. 2010 Jul;76(10):1014-7.?
molnova catalog
related products
  • GS-621763

    GS-621763, a prodrug of GS-441524, exhibits antiviral activity against SARS-CoV-2 pathogenesis.

  • Stearamide

    Stearamide(Stearic acid amide) is a primary fatty acid amide that is cytotoxic and fish toxic and can be used to increase the properties of nanoparticles.

  • Exendin-4 (3-39)

    Exendin-4 (3-39) is a peptide. Exendin-4 (3-39) is a truncated form of Exendin-4 that lacks the first two amino acids. Exendin-4 is a potent Glucagon-like peptide-1 receptor (GLP-1r) agonist. Exendin-4 (3-39) and Exendin-4 can be used for the research of diabetic and hypothalamic-pituitary-adrenal (HPA) axis.